MedPath

Tongji University Tongji Hospital of(Formerly Ganquan Hospital)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

Recruiting
Conditions
Esophageal Squamous Cell Carcinoma
Neoadjuvant Therapies
Interventions
Procedure: Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy
First Posted Date
2021-08-31
Last Posted Date
2021-08-31
Lead Sponsor
Tongji Hospital
Target Recruit Count
46
Registration Number
NCT05028231
Locations
🇨🇳

Tongji hospital, Wuhan, Hubei Provience, China

The Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart Failure

Not Applicable
Conditions
Heart Failure
Interventions
First Posted Date
2021-08-17
Last Posted Date
2021-08-17
Lead Sponsor
Tongji Hospital
Target Recruit Count
388
Registration Number
NCT05008679
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Longitudinal Changes in Characteristics of COVID-19 Survivors and Their Long-term Follow-up Study

Conditions
Prognosis
Sequelae
First Posted Date
2021-08-13
Last Posted Date
2024-03-18
Lead Sponsor
Tongji Hospital
Target Recruit Count
1000
Registration Number
NCT05004246
Locations
🇨🇳

Department of infectious disease, Tongji Hospital, Wuhan, Hubei, China

Calcitonin Level and New-onset of Post-Operative Atrial Fibrillation

Conditions
Calcitonin Secretion Disorder
Post-operative Atrial Fibrillation
Interventions
Procedure: Caridac surgery
First Posted Date
2021-08-06
Last Posted Date
2021-08-17
Lead Sponsor
Tongji Hospital
Target Recruit Count
200
Registration Number
NCT04993456
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Effect of Levosimendan on miRNAs Regulation in the Failing Hearts

Phase 4
Conditions
Heart Failure
Interventions
First Posted Date
2021-07-06
Last Posted Date
2021-07-16
Lead Sponsor
Tongji Hospital
Target Recruit Count
136
Registration Number
NCT04950569
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Application of Fecal Microbiota Transplantation in Children With ASD

Phase 1
Conditions
Autism Spectrum Disorder
Interventions
Biological: Fecal microbiota transplantation
First Posted Date
2021-07-02
Last Posted Date
2023-01-20
Lead Sponsor
Tongji Hospital
Target Recruit Count
40
Registration Number
NCT04948814
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Craniopharyngioma With Tumoral Hemorrhage

Completed
Conditions
Apoplexy
Craniopharyngioma
Interventions
Other: intratumoral hemorrhage
First Posted Date
2021-06-24
Last Posted Date
2021-06-24
Lead Sponsor
Tongji Hospital
Target Recruit Count
185
Registration Number
NCT04937335

Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults

First Posted Date
2021-06-01
Last Posted Date
2023-04-12
Lead Sponsor
Tongji Hospital
Target Recruit Count
650
Registration Number
NCT04908553
Locations
🇨🇳

TongjiHospital, Wuhan, China

Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

Phase 4
Conditions
Thrombocytopenia
Liver Failure
Decompensated Cirrhosis
Interventions
Drug: Standard medical treatment
First Posted Date
2021-05-28
Last Posted Date
2021-06-07
Lead Sponsor
Tongji Hospital
Target Recruit Count
150
Registration Number
NCT04906083
Locations
🇨🇳

Department of infectious disease, Tongji Hospital, Wuhan, Hubei, China

Effect of the Sheath of Rectus Abdominis Block Combined With the Transverse Plane

Not Applicable
Conditions
Nerve Block
Surgical Conditions
Interventions
Procedure: abdominal nerve block
First Posted Date
2021-04-20
Last Posted Date
2021-04-20
Lead Sponsor
Tongji Hospital
Target Recruit Count
42
Registration Number
NCT04850404
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy